Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Major Depressive Disorder

In brief

The purpose of this clinical research study is to learn whether BMS-562086 is both safe and effective in treating outpatients with major depressive disorder.

Key facts

Study ID
NCT00135421
Run by
Bristol-Myers Squibb
People needed
271
Starts
2005-11-01
Expected to finish
2007-10-01
Last updated by the study team
2010-03-02

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.